| Patents for C12P 21 - Preparation of peptides or proteins (112,499) | 
|---|
| 10/14/1993 | WO1993019782A1 Specific detection of cell surface receptor leukocyte adhesion molecule-1  | 
| 10/14/1993 | WO1993019777A1 Fusion proteins comprising tumor necrosis factor receptor  | 
| 10/14/1993 | WO1993019767A1 Cd28 pathway immunoregulation  | 
| 10/14/1993 | WO1993019761A1 Lipid-a analogs: new monosaccharide and disaccharide intermediates for eliciting therapeutic antibodies and for antitumor and antiviral activities  | 
| 10/14/1993 | WO1993014208A3 Hepatitis e virus vaccine and method  | 
| 10/14/1993 | DE4211517A1 Verfahren zur Herstellung rekombinanter Proteine in Streptomyceten A process for the production of recombinant proteins in streptomycetes  | 
| 10/14/1993 | CA2133662A1 Antibodies for treatment and prevention of respiratory syncytial virus infection  | 
| 10/14/1993 | CA2133443A1 Cloning, expression and uses of a novel secreted protein, f-spondin  | 
| 10/14/1993 | CA2133075A1 CD28 Pathway Immunoregulation  | 
| 10/14/1993 | CA2132624A1 Compositions and methods for regulating cellular signal transducing systems  | 
| 10/14/1993 | CA2126341A1 Lipid-a analogs: new monosaccharide and dissaccharide intermediates for eliciting therapeutic antibodies and for antitumor and antiviral activities  | 
| 10/14/1993 | CA2110295A1 Anti-hbs antibody genes and expression plasmids therefor  | 
| 10/13/1993 | EP0565511A1 Method of cleaving proteins  | 
| 10/13/1993 | EP0565370A1 Serotonin receptor protein and related DNA compounds  | 
| 10/13/1993 | EP0565208A1 DNA fragment encoding OspA of Borrelia burgdorferi, vaccine and diagnostics comprising OspA encoded by the DNA fragment  | 
| 10/13/1993 | EP0565164A1 Synthetic polypeptides as inhibitors of HIV-1  | 
| 10/13/1993 | EP0564592A1 Liver enriched transcription factor  | 
| 10/13/1993 | EP0564532A1 Polypeptides derived from proteins of the hepatitis c virus  | 
| 10/13/1993 | EP0540687A4 Antibody-mediated cofactor-driven reactions  | 
| 10/12/1993 | US5252708 Preparation process for a protein containing at least one intramolecular disulphide bridge by oxidation, at a pH of less than 5.0 of corresponding reduced recombinant protein  | 
| 10/12/1993 | US5252480 Human monoclonal antibody and hybridoma producing the same  | 
| 10/12/1993 | US5252469 Process for producing a transglutaminase derived from streptomyces  | 
| 10/12/1993 | US5252467 Method of making antibodies to antigenic epitopes of IGE present on B cells but not basophil cell surface or secreted, soluble IGE  | 
| 10/12/1993 | US5252465 Avian erythroblastosis virus vectors for integration and expression of heterologous genes in avian cells  | 
| 10/11/1993 | CA2093575A1 Human antithrombin iii mutant  | 
| 10/10/1993 | WO1993021305A1 MONOCLONAL ANTIBODY TO CELL SURFACE PROTEIN OF THE BACTERIUM $i(STREPTOCOCCUS PNEUMONIAE)  | 
| 10/10/1993 | CA2117794A1 Monoclonal antibody to cell surface protein of the bacterium streptococcus pneumoniae  | 
| 10/10/1993 | CA2093506A1 Serotonin receptor protein and related dna compounds  | 
| 10/07/1993 | CA2092776A1 A method of proteolytically cleaving proteins and the use of said method  | 
| 10/06/1993 | EP0564061A2 Method and apparatus for the in-vitro production of monoclonal antibodies high concentration  | 
| 10/06/1993 | EP0563714A2 TNF-Muteins  | 
| 10/06/1993 | EP0563627A2 Anti-tumor method and anti-tumor agent  | 
| 10/06/1993 | EP0563487A1 Monoclonal antibodies against the interferon receptor, with neutralizing activity against type I interferon  | 
| 10/06/1993 | EP0563383A1 (ganoderma lucidium) iy009 which produces proteoglycan (g009) having effect of enhancing antitumor immunity  | 
| 10/06/1993 | EP0563302A1 Method and apparatus for granulation  | 
| 10/06/1993 | EP0563296A1 Optimization of binding proteins  | 
| 10/06/1993 | EP0563240A1 Lipid receptors for microorganisms and corresponding adhesins, dna sequences encoding adhesins, and use thereof  | 
| 10/06/1993 | EP0563198A1 TARGETTING IgE EFFECTOR CELLS TO TUMOR CELLS  | 
| 10/06/1993 | EP0563175A1 A method of constructing synthetic leader sequences  | 
| 10/06/1993 | EP0563172A1 Synthetic bioadhesive polypeptide  | 
| 10/06/1993 | EP0563089A1 Serotonine receptor of class 1: the 5-ht 1x? receptors  | 
| 10/06/1993 | EP0556345A4 Retroviral vectors useful for gene therapy  | 
| 10/06/1993 | EP0454778A4 Molecules with antibody combining sites that exhibit stereospecific catalysis  | 
| 10/06/1993 | CN1076966A Cloning and expression of humanized monoclonal antibodies against human interleukin-4  | 
| 10/05/1993 | US5250426 Molecules with antibody combining sites that induce asymmetry  | 
| 10/05/1993 | US5250414 Diagnostic methods using neurite growth regulatory factors  | 
| 10/05/1993 | US5250305 Enzyme immobilized on spiral membrane; molecular weight control  | 
| 10/05/1993 | US5250201 Enhanced oil recovery using bioemulsifiers from cyanobacteria cultures  | 
| 10/05/1993 | CA1322735C Microorganism having low acetate forming capability, and process for production of useful substrate using same  | 
| 10/03/1993 | CA2091313A1 Tnf-muteins  | 
| 10/02/1993 | CA2093099A1 Recombinant human hiv-neutralizing monoclonal antibodies for prevention and treatment of hiv infection  | 
| 09/30/1993 | WO1993019373A1 Broadly reactive opsonic antibodies that react with common staphylococcal antigens  | 
| 09/30/1993 | WO1993019372A1 Method of detecting microorganisms  | 
| 09/30/1993 | WO1993019197A1 Human monoclonal antibodies and methods for human monoclonal antibody production  | 
| 09/30/1993 | WO1993019196A1 ANTI-CD3 AGLYCOSYLATED IgG ANTIBODY  | 
| 09/30/1993 | WO1993019195A1 A process for producing heme proteins  | 
| 09/30/1993 | WO1993019189A1 Enhanced expression in plants  | 
| 09/30/1993 | WO1993019188A1 Fungus-responsive chimaeric gene  | 
| 09/30/1993 | WO1993019180A1 Genetically engineered antibodies  | 
| 09/30/1993 | WO1993019179A1 Ifn receptors recognition factors, protein sequences and methods of use thereof  | 
| 09/30/1993 | WO1993019178A2 Peptides useful for inducing tolerance  | 
| 09/30/1993 | WO1993019176A1 Leucine zippers  | 
| 09/30/1993 | WO1993019175A1 Receptor for the glucagon-like-peptide-1 (glp-1)  | 
| 09/30/1993 | WO1993019174A1 Human t-cell marker ht6  | 
| 09/30/1993 | WO1993019165A1 Colon crypt cell mitogen, cell line producing it, and uses thereof  | 
| 09/30/1993 | WO1993019094A1 A monoclonal antibody to a human mdr1 multidrug resistance gene product, and uses  | 
| 09/30/1993 | WO1993019089A2 Oxygen carrier  | 
| 09/30/1993 | WO1993019085A1 Novel antler-derived bone growth factors  | 
| 09/30/1993 | WO1993019079A1 Systemin  | 
| 09/30/1993 | WO1993018792A1 Selective alteration of antibody immunogenicity  | 
| 09/30/1993 | WO1993018787A1 Trans-sialidase and methods of use and making thereof  | 
| 09/30/1993 | WO1993016185A3 Biosynthetic binding protein for cancer marker  | 
| 09/30/1993 | WO1993016099A3 Dna sequences encoding novel growth/differentiation factors  | 
| 09/30/1993 | WO1993015203A3 Polypeptides with fibronectin binding sites as modulators for matrix assembly  | 
| 09/30/1993 | WO1993012814A3 Vaccination and methods against diseases resulting from pathogenic responses by specific t cell populations  | 
| 09/30/1993 | WO1992001049A3 Cd53 cell surface antigen and use thereof  | 
| 09/30/1993 | CA2132345A1 Oxygen carrier  | 
| 09/30/1993 | CA2132323A1 Fungus-responsive chimaeric gene  | 
| 09/30/1993 | CA2132317A1 Ifn receptors recognition factors, protein sequences and methods of use thereof  | 
| 09/30/1993 | CA2132299A1 A process for producing heme proteins  | 
| 09/30/1993 | CA2132219A1 Novel antler-derived bone growth factors  | 
| 09/30/1993 | CA2132197A1 Systemin  | 
| 09/30/1993 | CA2132095A1 Colon crypt cell mitogen, cell line producing it, and uses thereof  | 
| 09/30/1993 | CA2131621A1 Selective alteration of antibody immunogenicity  | 
| 09/30/1993 | CA2130173A1 Genetically engineered antibodies  | 
| 09/29/1993 | EP0562508A2 Protein with bone formation ability and process for its production  | 
| 09/29/1993 | EP0562313A1 Biochemical cleavage of organic C-S bonds  | 
| 09/29/1993 | EP0562132A1 Monoclonal anti-tetanus toxin antibodies and pharmaceutical compositions containing them  | 
| 09/29/1993 | EP0562123A1 Novel physiologically active substance epimorphine, gene which codes for same, and antibody against epimorphine  | 
| 09/29/1993 | EP0562013A1 Human retrovirus receptor and dna coding therefor  | 
| 09/29/1993 | EP0561971A1 Fusion polypeptides  | 
| 09/29/1993 | EP0561960A1 Leukemia inhibitory factor receptors  | 
| 09/29/1993 | EP0561953A1 Recombinant immunotoxin composed of a single chain antibody reacting with the human transferrin receptor and diphtheria toxin  | 
| 09/29/1993 | EP0561907A1 Proteins with changed epitopes and methods for the production thereof  | 
| 09/29/1993 | EP0561890A1 Dna expression systems based on alphaviruses  | 
| 09/29/1993 | EP0561885A1 Subunit papillomavirus vaccine and peptides for use therein  | 
| 09/29/1993 | EP0561877A1 Compounds and compositions which inhibit bone resorption  | 
| 09/29/1993 | EP0480923B1 Method of producing proteins with fviii activity and/or fviii derivatives  | 
| 09/29/1993 | EP0353246B1 Sterol regulatory elements  | 
| 09/29/1993 | EP0305481B1 Leader sequences for the production of recombinant proteins  |